Phellodendrine

CAS No. 6873-13-8

Phellodendrine( —— )

Catalog No. M18997 CAS No. 6873-13-8

Phellodendrine has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 97 In Stock
10MG 165 In Stock
25MG 294 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phellodendrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Phellodendrine has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
  • Description
    Phellodendrine has anti-nephritic activity, may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6873-13-8
  • Formula Weight
    342.41
  • Molecular Formula
    C20H24NO4+
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (14.60 mM)
  • SMILES
    C[N+]12CCC3=CC(=C(C=C3C1CC4=CC(=C(C=C4C2)OC)O)O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nelivaptan

    Nelivaptan is a non-peptide vasopressin receptor antagonist, it is selective for the V1B subtype.

  • 3-Angeloyloxy-4-sene...

    3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.

  • Ofatumumab

    Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.